Skip to main content
NIH funding notice PAR-18-519

Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)

Closed on November 6, 2020.

Posted
December 20, 2017
Close date
November 6, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $15,445,754 in first-year total cost, median $746,569.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IFCN-B (55)]4
  2. Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]2
  3. Special Emphasis Panel[ZRG1-IFCN-B(55)]2
  4. Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]1
  5. Cognition and Perception Study Section[CP]1

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES2
  2. JOHNS HOPKINS UNIVERSITY2
  3. BAYLOR COLLEGE OF MEDICINE1
  4. BRIGHAM AND WOMEN'S HOSPITAL1
  5. HARVARD MEDICAL SCHOOL1
Competing awards under PAR-18-519 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Neurobehavioral phenotyping of AD model mice using Motion Sequencing1RF1AG073625-01DATTA, SANDEEP RHARVARD MEDICAL SCHOOL, MA$1,931,938CDIN
2021Contributions of modifiable physical attributes to cognitive and brain aging1R01AG068882-01A1HAYES, SCOTT MOHIO STATE UNIVERSITY, OH$648,003CP
2020The impact of aging and amyloidosis on interval timing in corticostriatal circuits and its rescue by controlled cholinergic fiber activation1RF1AG063783-01A1SHULER, MARSHALL GILMERJOHNS HOPKINS UNIVERSITY, MD$2,166,616SPC
2020Multisensory, Motor, and Biomarker Changes in Aging and Preclinical Alzheimer's Disease1RF1AG066837-01MERTEN, NATASCHAUNIVERSITY OF WISCONSIN-MADISON, WI$1,898,437NAME
2019Integrative Motor Activity Biomarker for the Risk of Alzheimer's Risk1RF1AG064312-01HU, KUNBRIGHAM AND WOMEN'S HOSPITAL, MA$3,584,687NAME
2019Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer’s Disease1R01AG062007-01RINGMAN, JOHN MUNIVERSITY OF SOUTHERN CALIFORNIA, CA$824,998ZRG1
2019Auditory, olfactory, and motor correlates of in-vivo AD neuropathology and cognitive decline in late-middle age1R56AG061817-01DEVANAND, DAVANGERE PLUCHSINGER, JOSE ALEJANDRORAO, ASHWINI K.COLUMBIA UNIVERSITY HEALTH SCIENCES, NY$821,822ZRG1
2019Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias1R01AG061786-01AGRAWAL, YURILIN, FRANK RSCHRACK, JENNIFER ANNJOHNS HOPKINS UNIVERSITY, MD$746,569ZRG1
2019Anosmia as a predictor of preclinical Alzheimer's disease1R56AG062454-01LOMVARDAS, STAVROSCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$649,633ZRG1
2019Synaptic decline in retina as a predictor of Alzheimer's disease1R56AG061808-01SAMUEL, MELANIE ABAYLOR COLLEGE OF MEDICINE, TX$628,320ZRG1
2019Multi-Domain Sensory Measures as Biomarkers of Alzheimer's Disease in Preclinical and Prodromal Stages1R01AG061788-01RISACHER, SHANNON LINDIANA UNIVERSITY INDIANAPOLIS, IN$611,139ZRG1
2019Olfactory and Visual Dysfunction as Potential Predictors of Preclinical Alzheimer's Disease1R01AG062006-01MURPHY, CLAIRE LSAN DIEGO STATE UNIVERSITY, CA$597,592ZRG1
2019Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease1R01AG061811-01A1SEPULCRE, JORGEMASSACHUSETTS GENERAL HOSPITAL, MA$336,000SMI

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-519: Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed) | ScienceDex | ConductScience